Across the world, rising infertility rates have led to increasing demand for in vitro fertilisation (IVF) treatment, including in countries such as Bangladesh. However, despite its growing medical importance, IVF remains financially inaccessible for many couples due to its high cost. Health experts and policy analysts note that the inclusion of IVF within insurance coverage could improve access to treatment and support more consistent completion of medical cycles.
IVF is a structured assisted reproductive technology that involves several distinct stages. These typically include hormonal stimulation of the ovaries to produce eggs, retrieval of those eggs, fertilisation in a controlled laboratory environment, and the transfer of resulting embryos into the uterus. A complete IVF cycle generally requires two to three weeks. However, medical outcomes are often dependent on more than one cycle, as success is not guaranteed in a single attempt.
Clinical evidence shows that success rates vary significantly depending on age. For women under 35 years, the average success rate per IVF cycle is approximately 50 to 55 per cent. For those aged between 38 and 40, the success rate falls to around 20 to 30 per cent. The probability of success continues to decline with increasing age beyond this range.
The cost of IVF treatment remains a major barrier globally. In the United States, a single cycle typically costs between USD 12,000 and USD 30,000, excluding additional expenses such as medication and related procedures. In European countries, although the cost is generally lower, it still amounts to several thousand euros per cycle. These financial demands often lead patients to delay treatment or discontinue it before completing the recommended number of cycles.
Medical professionals consistently identify cost as the most significant obstacle to infertility treatment. Many couples begin IVF but are unable to complete full treatment plans due to financial pressure. In countries where IVF is covered by insurance systems, either partially or fully, patients are more likely to complete multiple cycles. Such systems are also associated with clinical practices that reduce health risks, including limiting the number of embryos transferred to minimise multiple pregnancies.
In the United States, insurance coverage for infertility treatment exists in certain states, although it is often restricted by limits on the number of cycles or total expenditure. In several European countries, public healthcare systems provide broader coverage. For example, in the Netherlands, up to three IVF or intracytoplasmic sperm injection (ICSI) cycles may be covered under specific eligibility conditions.
In Bangladesh, IVF treatment is largely self-financed. Although private fertility clinics offer advanced reproductive services, no insurance provider currently includes IVF within standard health insurance policies. Analysts attribute this to limited development of specialised insurance products and relatively low penetration of comprehensive health coverage.
IVF Cost and Insurance Coverage Overview
| Region / Country |
Cost per IVF Cycle |
Insurance Coverage Status |
Key Features |
| United States |
USD 12,000–30,000 |
Partial, varies by state |
Limits on cycles or spending in some regions |
| Europe (general) |
Several thousand euros |
Partial to substantial |
Public healthcare support in selected countries |
| Netherlands |
Not fixed (covered cycles) |
Up to 3 cycles under conditions |
Included in public health system |
| Bangladesh |
High relative to income |
Not covered |
Out-of-pocket payment in private clinics |
Experts suggest that expanding IVF insurance coverage could improve access to fertility treatment while also strengthening health insurance markets. As awareness of infertility increases, some countries and employers are gradually considering fertility-related benefits as part of broader healthcare provisions for employees.
Comments